Urinary Incontinence Surgery Won't Raise a Woman's Cancer Risk
NDAY, April 12, 2021 -- Women face no increased risk of pelvic cancer -- tumors of the bladder, cervix and ovaries -- if they have surgery to treat stress urinary incontinence (SUI), a new study finds. Concerns about possible complications and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 12, 2021 Category: General Medicine Source Type: news

Personalized cancer vaccine is safe, shows potential benefit against cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 10, 2021 Category: Cancer & Oncology Source Type: news

Genes and immune cells predict immunotherapy success in bladder cancer
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder have been identified and validated by researchers at Mount Sinai. In a study published in Clinical Cancer Research, the team uncovered gene signatures representing adaptive immunity and pro-tumorigenic inflammation that were responsible for sensitivity or resistance to immune checkpoint inhibitors, drugs that help the body's immune system recognize and attack cancerous cells. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 9, 2021 Category: Cancer & Oncology Source Type: news

Resistance to Immunotherapy in Patients with Urothelial Bladder Cancer...
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of the bladder have been identified and validated by researchers at Mount Sinai. In a study...(PRWeb April 09, 2021)Read the full story at https://www.prweb.com/releases/resistance_to_immunotherapy_in_patients_with_urothelial_bladder_cancer_is_traced_to_specific_sets_of_immune_cells/prweb17850269.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - April 9, 2021 Category: Pharmaceuticals Source Type: news

Artist Tracey Emin says her cancer is 'gone'
The 57-year-old was diagnosed with a "really rapid, really aggressive" bladder cancer last year. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - April 8, 2021 Category: Consumer Health News Source Type: news

Testing a new way to tackle cancer
(Michigan State University) A potential new weapon against cancer is entering the first phase of clinical trials. Michigan State University's Kurt Zinn, a professor of biomedical engineering, radiology and small animal clinical sciences, is leading the effort to validate an innovative radiotherapy as part of a safe, more effective and potentially less costly treatment for bladder cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 6, 2021 Category: International Medicine & Public Health Source Type: news

Phase III Trial of Durvalumab for Mesothelioma Underway
The U.S. Food and Drug Administration will be closely watching the latest, international phase III clinical trial for unresectable pleural mesothelioma involving the immunotherapy drug durvalumab. FDA approval may be coming soon. “It looks very promising,” Dr. Arkadiusz Dudek, of Regions Hospital Cancer Care Center in St. Paul, Minnesota, told The Mesothelioma Center at Asbestos.com. “The hope is to have the regimen approved by the FDA as front-line therapy. There is a real need today for more options with mesothelioma.” The goal of the randomized trial – officially known as DREAM3R &...
Source: Asbestos and Mesothelioma News - April 1, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

New study looks at long-term outcomes and costs of NMIBC
(University of Texas Medical Branch at Galveston) A new study published in JAMA Network Open details the results of treatment outcomes and the costs of medical care for patients with advanced bladder cancer using VA data over 15 years. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 31, 2021 Category: Cancer & Oncology Source Type: news

Decades of radiation-based scientific theory disproven by Ben-Gurion University US-based study
(American Associates, Ben-Gurion University of the Negev) According to the study, lower levels of several types of cancers were found when the radiation levels were on the higher end of the spectrum rather than on the lower end. Among both men and women, there was a significant decrease in lung, pancreatic, colon and rectal cancers. Among men, there were additional decreases in brain and bladder cancers. There was no decrease in cervix, breast or prostate cancers or leukemia. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 24, 2021 Category: International Medicine & Public Health Source Type: news

New breed of drug that reduces deaths from bladder cancer
The medicines, which are known as antibody-drug conjugates (ADCs), carry out chemotherapy-like attacks on cancer cells but don't cause side effects such as hair loss, fatigue and nausea. (Source: the Mail online | Health)
Source: the Mail online | Health - March 20, 2021 Category: Consumer Health News Source Type: news

Janssen Announces U.S. FDA Approval of PONVORY ™ (ponesimod), an Oral Treatment for Adults with Relapsing Multiple Sclerosis Proven Superior to Aubagio® (teriflunomide) in Reducing Annual Relapses and Brain Lesions
TITUSVILLE, N.J. – (March 19, 2021) – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) approved PONVORY™ (ponesimod), a once-daily oral selective sphingosine-1-phosphate receptor 1 (S1P1) modulator, to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease.1,2,3 PONVORY™ offers MS patients superior efficacy in reducing annualized relapse rates compared to an established oral therapy and a proven safety profi...
Source: Johnson and Johnson - March 19, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Roche provides update on Tecentriq US indication in prior-platinum treated metastatic bladder cancer
This study did not meet its primary endpoint of overall survival in the PD-L1 high patient population. Subsequently, the FDA designated the IMvigor130 study as the PMR which will still continue until the final analysis. However, as the treatment landscape in prior-platinum (second-line) mUC has rapidly evolved with the emergence of new treatment options, Roche is voluntarily withdrawing this indication in recognition of the principles of the Accelerated Approval Program.About Tecentriq Tecentriq is a monoclonal antibody designed to bind with a protein called Programmed Death Ligand-1 (PD-L1), which is expressed on tumour c...
Source: Roche Media News - March 8, 2021 Category: Pharmaceuticals Source Type: news

Roche provides update on Tecentriq US indication in prior-platinum treated metastatic bladder cancer
This study did not meet its primary endpoint of overall survival in the PD-L1 high patient population. Subsequently, the FDA designated the IMvigor130 study as the PMR which will still continue until the final analysis. However, as the treatment landscape in prior-platinum (second-line) mUC has rapidly evolved with the emergence of new treatment options, Roche is voluntarily withdrawing this indication in recognition of the principles of the Accelerated Approval Program.About Tecentriq Tecentriq is a monoclonal antibody designed to bind with a protein called Programmed Death Ligand-1 (PD-L1), which is expressed on tumour c...
Source: Roche Investor Update - March 8, 2021 Category: Pharmaceuticals Source Type: news

Recurring Urinary Tract Infections May Play A Role In Bladder Cancer
A recent study published in PLOS Pathogens has found that a DNA-damaging bacterial toxin called colibactin is produced in people with UTIs. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 28, 2021 Category: Pharmaceuticals Authors: Anuradha Varanasi, Contributor Tags: Healthcare /healthcare Innovation /innovation Source Type: news

Study: Bladder cancer is more advanced in South Texas
(University of Texas Health Science Center at San Antonio) A study by the Mays Cancer Center, home to UT Health San Antonio MD Anderson, found bladder cancer is more advanced and more aggressive in South Texas compared to other areas of the U.S. Latinos and women have reduced five-year survival rates from bladder cancer, the analysis also found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 25, 2021 Category: Cancer & Oncology Source Type: news

Bladder Cancer Indication Withdrawn for Durvalumab Bladder Cancer Indication Withdrawn for Durvalumab
AstraZeneca is withdrawing durvalumab's indication for the treatment of metastatic bladder cancer after a phase 3 trial showed no survival benefit.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 23, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Oncotarget: MEK is a promising target in the basal subtype of bladder cancer
(Impact Journals LLC) " The @Oncotarget authors demonstrate that MEK inhibitors are a promising targeted therapy for the basal subtype of bladder cancer, and their data indicate that drug screening of 3D cultures provides an important resource for hypothesis generation " (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 22, 2021 Category: Cancer & Oncology Source Type: news

High-speed radiotherapy can blast away bladder cancer... in just FOUR weeks 
A landmark study has proved that an intense 20-day course of the treatment is more effective than lower doses given over six weeks - once the standard option. (Source: the Mail online | Health)
Source: the Mail online | Health - February 20, 2021 Category: Consumer Health News Source Type: news

Know the Signs of Rare But Deadly Gall Bladder, Bile Duct Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 16, 2021 Category: Cancer & Oncology Tags: Gastroenterology, Hepatology, Oncology, News, Source Type: news

Know the Signs of Rare But Deadly Gall Bladder, Bile Duct Cancers
TUESDAY, Feb. 16, 2021 -- Most people aren't aware of the signs of gallbladder or bile duct cancer, but the Rutgers Cancer Institute of New Jersey says they should be. The gallbladder is a small organ connected to the liver by bile ducts. Its job... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 16, 2021 Category: General Medicine Source Type: news

Know the Signs of Rare But Deadly Gall Bladder, Bile Duct Cancers
Title: Know the Signs of Rare But Deadly Gall Bladder, Bile Duct CancersCategory: Health NewsCreated: 2/16/2021 12:00:00 AMLast Editorial Review: 2/16/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 16, 2021 Category: Cancer & Oncology Source Type: news

New class of drug leads to 30% reduced risk of death for bladder cancer patients
(Queen Mary University of London) A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a phase III clinical trial led in the UK by Queen Mary University of London and Barts Health NHS Trust. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 12, 2021 Category: Cancer & Oncology Source Type: news

Aspirin Linked to Reduced Bladder, Breast Cancer Mortality Aspirin Linked to Reduced Bladder, Breast Cancer Mortality
Regular aspirin use in older people shows no reduction in the incidence of some cancers, but some mortality reductions were seen in an observational study that used data from a large US cohort.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 1, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Prostate cancer symptoms: Nocturia could be a sign of the disease - do you have it?
PROSTATE cancer symptoms emerge when the tumour is large enough to press against the urethra - the tube that carries urine from the bladder out of the body through the tip of the penis. What are the signs of the disease? (Source: Daily Express - Health)
Source: Daily Express - Health - January 30, 2021 Category: Consumer Health News Source Type: news

Aspirin Use Tied to Longer Bladder, Breast Cancer Survival
However, aspirin use in older adults not tied to incidence of various cancer types (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 27, 2021 Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Urology, Journal, Source Type: news

Aspirin Use Tied to Longer Bladder, Breast Cancer Survival
WEDNESDAY, Jan. 27, 2021 -- Aspirin use may improve survival for bladder and breast cancer, according to a study published online Jan. 15 in JAMA Network Open. Holli A. Loomans-Kropp, Ph.D., M.P.H., from the National Cancer Institute in Rockville,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2021 Category: Pharmaceuticals Source Type: news

Regular aspirin use can lower risk for death in bladder, breast cancers, study finds
People who take aspirin at least three times per week are more likely to survive bladder cancer, according to an analysis published Friday by JAMA Network Open. (Source: Health News - UPI.com)
Source: Health News - UPI.com - January 15, 2021 Category: Consumer Health News Source Type: news

Bladder cancer -- When to use chemotherapy
(Charit é - Universit ä tsmedizin Berlin) In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body's immune system response to the malignancy. This is the conclusion of research conducted by a team of scientists from Charit é -- Universit ä tsmedizin Berlin and the Berlin Institute of Health. The findings, which have been published in Science Translational Medicine*, can be used to predict treatment success and may increase survival in patients with bladder cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 14, 2021 Category: Cancer & Oncology Source Type: news

MD Anderson and UroGen Pharma announce strategic research collaboration to advance investigational treatment for high-grade bladder cancer
(University of Texas M. D. Anderson Cancer Center) MD Anderson and UroGen today announced a strategic three-year collaboration agreement to advance combination immunotherapy, delivered directly into the bladder, for the treatment of high-grade non-muscle invasive bladder cancer. The collaboration will work through MD Anderson's immunotherapy platform to design pre-clinical and clinical studies. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 13, 2021 Category: International Medicine & Public Health Source Type: news

Bladder cancer symptoms: Is your pee brown? You could be at risk of the deadly disease
BLADDER cancer is the tenth most common cancer in the UK, with around 10,000 people diagnosed with it every year. One of the main symptoms is a colour change in your urine. (Source: Daily Express - Health)
Source: Daily Express - Health - January 8, 2021 Category: Consumer Health News Source Type: news

Bladder cancer symptoms: The colour of your urine could pinpoint the deadly disease
BLADDER cancer is twice as likely to occur in men than women, especially for those over the age of 50. Would you know what to look for in order to seek medical treatment? Find out here. (Source: Daily Express - Health)
Source: Daily Express - Health - December 17, 2020 Category: Consumer Health News Source Type: news

Physicians often miss rad therapy side effects
Physicians often missed key side effects of radiation therapy in patients with...Read more on AuntMinnie.comRelated Reading: Skipping rad therapy may not hinder breast cancer survival Radiation therapy takes toll on prostate cancer patients' finances Race, ethnicity vary in radiation therapy trials Radiation therapy access grows, but not in rural areas Daily radiation-chemo helps save bladder in cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 10, 2020 Category: Radiology Source Type: news

Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020
Basel, 10 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today presented an exploratory analysis from the Phase III IMvigor010 study evaluating Tecentriq ® (atezolizumab), compared with observation, as an adjuvant (after surgery) monotherapy treatment for people with muscle-invasive urothelial cancer (MIUC) at the European Society for Medical Oncology Immuno-Oncology (ESMO IO) Virtual Congress, 9–12 December 2020. (Source: Roche Investor Update)
Source: Roche Investor Update - December 10, 2020 Category: Pharmaceuticals Source Type: news

Roche presents exploratory data from the Phase III IMvigor010 study in early bladder cancer at the ESMO Immuno-Oncology Virtual Congress 2020
Basel, 10 December 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today presented an exploratory analysis from the Phase III IMvigor010 study evaluating Tecentriq ® (atezolizumab), compared with observation, as an adjuvant (after surgery) monotherapy treatment for people with muscle-invasive urothelial cancer (MIUC) at the European Society for Medical Oncology Immuno-Oncology (ESMO IO) Virtual Congress, 9–12 December 2020. (Source: Roche Media News)
Source: Roche Media News - December 10, 2020 Category: Pharmaceuticals Source Type: news

Novel Gene Therapy Wows for BCG-Unresponsive Bladder Cancer Novel Gene Therapy Wows for BCG-Unresponsive Bladder Cancer
A novel gene therapy for BCG-unresponsive NMIBC, nadofaragene firadenovec, is being suggested as a"new gold standard" for these patients.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - December 8, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Groundbreaking urine test that can spot bladder cancer proves 100% accurate in trials
The pioneering liquid biopsy could replace the dipstick test currently used by GPs (pictured) as a first check for the life-threatening condition. (Source: the Mail online | Health)
Source: the Mail online | Health - December 5, 2020 Category: Consumer Health News Source Type: news

Incidence and risk factors of suicide among patients diagnosed with bladder cancer: a systematic review and meta-analysis - Guo Z, Gu C, Li S, Gan S, Li Y, Xiang S, Gong L, Wang S.
This study aimed to assess how bladder cancer increases suicide risk and to identify the demographic and clinical factors associated with suicidal death among patients with bladder ca... (Source: SafetyLit)
Source: SafetyLit - December 5, 2020 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Burden of non-muscle invasive bladder cancer substantial
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - December 1, 2020 Category: Drugs & Pharmacology Source Type: news

Breast Cancer, CRC Incidence No Different With, Without MS
However, bladder cancer incidence and mortality rates higher among individuals with multiple sclerosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 30, 2020 Category: Cancer & Oncology Tags: Gastroenterology, Gynecology, Internal Medicine, Neurology, Oncology, Urology, Journal, Source Type: news

Breast Cancer, CRC Incidence No Different With, Without MS
MONDAY, Nov. 30, 2020 -- The incidence of and mortality rates for breast and colorectal cancers do not differ for individuals with and without multiple sclerosis (MS), while bladder cancer incidence and mortality rates are higher for MS patients,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 30, 2020 Category: Pharmaceuticals Source Type: news

Quit Smoking, Your Bladder Will Thank You
THURSDAY, Nov. 26, 2020 -- If you smoke, you significantly increase your odds of developing bladder cancer, experts warn. " Everyone knows smoking causes lung cancer, but they don't always know about bladder cancer, " said Dr. Srinivas Vourganti, a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 26, 2020 Category: General Medicine Source Type: news

MS Has Mixed Impact on Patients' Cancer Risk: Study
WEDNESDAY, Nov. 25, 2020 -- How does having multiple sclerosis (MS) affect a person's odds for cancer? The answer may depend on the type of cancer, new research shows. The study found that MS patients do have much greater odds of developing bladder... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 25, 2020 Category: General Medicine Source Type: news

Multiple sclerosis may not put you at risk for breast, colorectal cancers
(American Academy of Neurology) People with multiple sclerosis (MS) may not be at higher risk of developing two of the three cancers that occur most commonly in people with MS, breast and colorectal cancer, than people who don't have the disease, according to a new study published in the November 25, 2020, online issue of Neurology ® , the medical journal of the American Academy of Neurology. However, the study did find that people with MS had a higher incidence of bladder cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 25, 2020 Category: Cancer & Oncology Source Type: news

Cancer Prevention and Screening for Older Adults Cancer Prevention and Screening for Older Adults
This review addresses special considerations regarding prevention and early identification of lung, colorectal, bladder, and kidney cancer for adults aged 65 and older.Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 18, 2020 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Mesothelioma Surgery with Organ Removal Extends Survival
Removing major organs to achieve a more complete cancer resection did not increase severe complications or hinder survival benefits of aggressive surgery for patients with peritoneal mesothelioma, according to a recent report. The increased complexity of organ resection surgery will not adversely affect long-term outcomes, according to the multicenter study published in Annals of Surgical Oncology. By comparison, an incomplete cytoreduction that can spare the organs is associated with increased mortality and shorter overall survival. The study, which involved 174 patients across 12 specialty centers within the U.S., accent...
Source: Asbestos and Mesothelioma News - November 17, 2020 Category: Environmental Health Authors: Fran Mannino Source Type: news

Houston country star Doug Supernaw dies of cancer at age 60
Country singer Doug Supernaw grew up in Houston’s Inwood Forest. He died Friday, nine months after being diagnosed with lung and bladder... (Source: Reuters: Health)
Source: Reuters: Health - November 14, 2020 Category: Consumer Health News Source Type: news

Sussex research points to new effective breast cancer treatment
(Diamond Light Source) An international five-year study led by scientists at the University of Sussex has provided strong evidence for an effective new target for breast cancer treatment. The study, The structure-function relationship of oncogenic LMTK3 being published in Science Advances, involved researchers from seven institutions across three countries including the UKs Diamond Light Source. It suggests LMTK3 inhibitors could be effectively used for treatment of breast cancer, and potentially other types of cancer such as lung, stomach, thyroid and bladder cancer patients (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 13, 2020 Category: Cancer & Oncology Source Type: news

What Is the Main Cause of Bladder Cancer
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 3, 2020 Category: General Medicine Source Type: news

Patients with Tracey Emin's cancer welcome new treatment plans
Turner Prize nominated artist Tracey Emin said she has an aggressive form of bladder cancer. Some 10,000 Britons a year receive a similar diagnosis and up to two-thirds of them will die within a year. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2020 Category: Consumer Health News Source Type: news

Daily radiation-chemo helps save bladder in cancer patients
A regimen of gemcitabine chemotherapy with daily radiation therapy led to good...Read more on AuntMinnie.comRelated Reading: PET with Axumin boosts prostate cancer outcomes Single-session SBRT speeds treatment of lung metastases Photon IMRT falls short in glioblastoma study Stereotactic body radiation eases spinal cancer pain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 28, 2020 Category: Radiology Source Type: news